Tibbs Zachary E, Falany Charles N
The Department of Pharmacology and Toxicology, The University of Alabama at Birmingham School of Medicine, Birmingham, AL 35294-0019, United States.
Biochem Pharmacol. 2016 Sep 1;115:123-33. doi: 10.1016/j.bcp.2016.06.011. Epub 2016 Jun 23.
Cytosolic sulfotransferases (SULTs) biotransform small molecules to polar sulfate esters as a means to alter their activities within the body. Understanding the molecular mechanism by which the SULTs perform their function is important for optimizing future therapeutic applications. Recent evidence suggests each SULT isoform acts by a half-site reaction (HSR) mechanism, in which a single SULT dimer subunit is active at any given time. HSR requires communication through the highly conserved KxxxTVxxxE dimerization motif. In this investigation, we sought to test the intersubunit interactions of SULT1B1 as it relates to enzyme activity. We generated two populations of SULT1B1 isoforms that efficiently heterodimerize upon mixing by targeted point mutation of the KxxxTVxxxE motif to KxxxTVxxxK or ExxxTVxxxE. The heterodimer exhibited wildtype-like activity with regard to native size, thermal integrity, PAP affinity, and PAPS Km, therefore serving as a valid model for investigating SULT1B1 dimer subunit interactions. The approach granted control over each independent subunit, permitting mutation of the critical 3'-phosphoadenosine 5'-phosphosulfate (PAPS) binding residue Arg258 and/or the catalytic base His109 in a single subunit of the dimer. Substitution of the dysfunctional subunits for fully active subunits yielded dimeric SULT1B1 with 50% the activity of the fully competent dimer, suggesting SULT1B1 intersubunit communication does not significantly contribute to the isoform's activity. These results are a testament to the unique properties of individual SULT isoforms. The dimerization system described in this manuscript can be used to study subunit interactions in other SULT isoforms as well as proteins in other families.
胞质磺基转移酶(SULTs)将小分子生物转化为极性硫酸酯,以此改变它们在体内的活性。了解SULTs发挥功能的分子机制对于优化未来的治疗应用至关重要。最近的证据表明,每个SULT同工型通过半位点反应(HSR)机制发挥作用,即在任何给定时间,单个SULT二聚体亚基是有活性的。HSR需要通过高度保守的KxxxTVxxxE二聚化基序进行通讯。在本研究中,我们试图测试与酶活性相关的SULT1B1亚基间相互作用。我们通过将KxxxTVxxxE基序靶向点突变为KxxxTVxxxK或ExxxTVxxxE,生成了两个群体的SULT1B1同工型,它们在混合时能有效异源二聚化。该异源二聚体在天然大小、热稳定性、PAP亲和力和PAPS Km方面表现出类似野生型的活性,因此可作为研究SULT1B1二聚体亚基相互作用的有效模型。该方法允许对每个独立亚基进行控制,从而能够在二聚体的单个亚基中突变关键的3'-磷酸腺苷5'-磷酸硫酸酯(PAPS)结合残基Arg258和/或催化碱基His109。用功能失调的亚基替换完全活性的亚基,产生的二聚体SULT1B1活性为完全有活性二聚体的50%,这表明SULT1B1亚基间通讯对该同工型的活性没有显著贡献。这些结果证明了各个SULT同工型的独特性质。本手稿中描述的二聚化系统可用于研究其他SULT同工型以及其他家族蛋白质中的亚基相互作用。